Loading...

HYPOMYELINATION SYNDROME GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited 
The Hypomyelination Syndrome Gene Panel by NGS analyzes genes responsible for defective myelin formation in the central nervous system. Using an EDTA blood sample, this test identifies inherited variants linked to delayed myelination, motor difficulties, and neurological impairment. Metropolis Healthcare utilizes advanced next-generation sequencing to deliver precise and comprehensive genetic insights. The results support early diagnosis, clinical decision-making, and family counseling for suspected hypomyelination disorders 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:G0211

Frequently Asked Questions (FAQ's):

What does the Hypomyelination Syndrome Gene Panel include at Metropolis Healthcare?
It covers essential genes involved in myelin production and maintenance, analyzed using high-accuracy NGS technology.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from an EDTA blood sample and sequences targeted genes to detect clinically relevant mutations.

Who should consider this test at Metropolis Healthcare?
Patients with delayed motor milestones, neurological regression, or MRI evidence of hypomyelination may benefit from this panel.

What sample does Metropolis Healthcare require for this test?
A standard EDTA blood sample is used to obtain high-quality DNA for next-generation sequencing.

How long does Metropolis Healthcare take to provide results?
Reports are delivered within a standard genetic testing timeframe following comprehensive sequencing and expert review.

Why choose Metropolis Healthcare for hypomyelination testing?
Metropolis Healthcare offers advanced sequencing, broad gene coverage, and clinically actionable genetic interpretation.

Does Metropolis Healthcare provide post-test support?
Yes, detailed insights accompany the report to assist clinicians in diagnosis, management, and family guidance.

Is this test suitable for children at Metropolis Healthcare?

Yes, the panel is appropriate for infants, children, and adults with suspected hypomyelination syndromes 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab